News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wong Stephanie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Wong Stephanie (Director) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Granted 23,742 options to buy
@ $5.91, valued at
$140.3k
|
|
| 01/25/2023 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 317 shares
@ $0.4461, valued at
$141.4 |
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2022 |
3
| Wong Stephanie (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 01/27/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 215,000 options to buy
@ $0.44, valued at
$94.6k
|
|
| 01/25/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 5,586 shares
@ $0.4915, valued at
$2.7k
|
|
| 01/06/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 18,077 shares
@ $0.6604, valued at
$11.9k
|
|
| 11/09/2021 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Paid exercise price by delivering 15,566 shares
@ $0.87, valued at
$13.5k
|
|
| 10/29/2021 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 90,000 shares
@ $0
Paid exercise price by delivering 45,965 shares
@ $1.89, valued at
$86.9k
|
|
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Wong Stephanie (SR. VP, FINANCE & SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $8, valued at
$40k
|
|
| 01/22/2020 |
4
| Wong Stephanie (SR. VP, FINANCE & SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 120,000 options to buy
@ $7.41, valued at
$889.2k
|
|
| 06/21/2019 |
4
| Wong Stephanie (SR. VP, FINANCE & SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.64, valued at
$26.4k
|
|
| 01/14/2019 |
4
| Wong Stephanie (SR. VP, FINANCE & SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 120,000 options to buy
@ $4.64, valued at
$556.8k
|
|
| 02/27/2018 |
4
| Wong Stephanie (SR VP, FINANCE AND SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.64, valued at
$26.4k
|
|
| 01/16/2018 |
4
| Wong Stephanie (SR. VP, FINANCE & SECRETARY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 70,000 options to buy
@ $8.6, valued at
$602k
|
|
| 07/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/10/2012 |
3
| Wong Stephanie (VP, Finance and Controller) has filed a Form 3 on SCICLONE PHARMACEUTICALS INC |
|
|